Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Van Steeg, H.
Right arrow Articles by Van Kreijl, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Steeg, H.
Right arrow Articles by Van Kreijl, C. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Use of DNA Repair-Deficient XPA Transgenic Mice in Short-Term Carcinogenicity Testing

Harry Van Steeg

Laboratory of Health Effects Research, National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands, H.van.Steeg{at}rivm.nl

Hanneke Klein

Laboratory of Health Effects Research, National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands

Rudolf B. Beems

Laboratory for Pathology and Immunobiology, National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands

Coen F. Van Kreijl

Laboratory of Health Effects Research, National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands

At present (putative) human carcinogens are identified via epidemiological studies and testing using the chronic 2-yr rodent bioassay. Both methods have severe limitations in that they are slow, insensitive, expensive, and are also hampered by many uncertainties. The development of methods to modify specific genes in the mammalian genome has provided promising new tools for use in identifying carcinogens and characterizing their (qualitative) risk. Several transgenic mouse lines are currently under study to test their possible use in short-term carcinogenicity testing. One such candidate alternative transgenic model is the XPA knock-out mouse. These mice have an almost complete deficiency in DNA nucleotide excision repair (NER). Nevertheless, XPA-deficient mice are viable and have a background of a low incidence of spontaneous development of cancers. Approximately 15% of the mice develop hepatocellular adenomas (only after 1.5 yr). After treatment with ultraviolet-B radiation or 7,12-dimethylbenz(a)anthracene, the XPA-deficient mice developed squamous cell carcinomas and papillomas, respectively, on their skin. Oral treatment of XPA-deficient mice with benzo[a]pyrene (B[a]P), 2-acetylaminofluorene (2-AAF), and 2-amino-l-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP) resulted in lymphomas (B[a]P), liver and bladder tumors (2-AAF), and intestinal adenomas plus lymphomas (PhIP). These results look encouraging, but it should be noted that the compounds and agents tested thus far have all been substrate for nucleotide excision repair. Animal studies with different genotoxic or nongenotoxic compounds, as organized for instance within the framework of the International Life Sciences Institute/Health and Environmental Sciences Institute program, are needed to further evaluate the suitability of the XPA model for short-term carcinogenicity testing.

Key Words: XPA • xeroderma pigmentosum • transgenic mice • carcinogenicity testing • genotoxic • DNA repair • nucleotide excision repair

  • Ames BN and Gold LS (1990). Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA 87: 7772-7776.[Abstract/Free Full Text]
  • Asahina H., Kuraoka I., Shirakawa M., Morita EH, Miura N., Miyamoto I., Ohtsuka E., Okada Y., and Tanaka K. (1994). The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage. Mutat. Res. 315: 229-237.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Baker SM, Bronner CE, Zhang L., Plug AW, Robatzek M., Warren G., Elliott EA, Yu J., Ashley T., Arnheim N., Flavell RA, and Liskay RM (1995). Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309-319.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bohr VA, Smith CA, Okumoto DS, and Hanawalt PC (1985). DNA repair in an active gene: Removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40: 359-369.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chen M., Tomkins DJ, Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos CJ, Freedman MH, Cross J., Percy DH, Dick JE, Joyner AL, and Buchwald M. (1996). Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12: 448-451.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cheo DL, Ruven HJ, Meira LB, Hammer RE, Bums DK, Tappe NJ, Van Zeeland AA, Mullenders LH, and Friedberg EC (1997). Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res. 374: 1-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Chu G. and Mayne L. (1996). Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy: Do the genes explain the diseases? Trends Genet. 12: 187-192.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cleaver JE and Kraemer KH (1989). Xeroderma pigmentosum. In: The Metabolic Basis of Inherited Disease, Vol. 2, CR Scriver, AL Beaudet, WS Sly, and D Valle (eds). McGraw-Hill, New York, pp. 2949-2971.
  • Cleaver JE and Kraemer KH (1995). Xeroderma pigmentosum and Cockayne syndrome. In: The Metabolic and Molecular Basis of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, and D Valle (eds), Vol. III, 7th ed., McGraw-Hill, New York, pp. 4393-4419.
  • Cooper PK, Nouspikel T., Clarkson SG, and Leadon SA (1997). Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G. Science 275: 990-993.[Abstract/Free Full Text]
  • Croteau DL and Bohr VA (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272:25409-25412.[Free Full Text]
  • De Vries A., Van Oostrom CThM, Dortant PM, Beems RB, Van Kreijl CF, Capel PJA, and Van Steeg H. (1997). Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinog. 19: 46-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • De Vries A., Van Oostrom CThM, Hofhuis FMA, Dortant PM, Berg RJW, De Gruijl FR, Wester PW, Van Kreijl CF, Capel PJA, Van Steeg H., and Verbeek S. (1995). Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377: 169-173.[CrossRef][Medline] [Order article via Infotrieve]
  • De Wind N., Dekker M., Berns A., Radman M., and Te Riele H. (1995). Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82: 321-330.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Donehower LA, Harvey M., Slagle BL, McArthur MJ, Montgomery CA, Butel JS, and Bradley A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.[CrossRef][Medline] [Order article via Infotrieve]
  • Edelmann W., Cohen PE, Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard JW, Kolodner RD, and Kucherlapati R. (1996). Meiotic pachytene arrest in MLH1-deficient mice. Cell 85: 1125-1134.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Engelward BP, Weeda G., Wyatt MD, Broekhof JL, de Wit J., Donker I., Allan JM, Gold B., Hoeijmakers JHJ, and Samson LD (1997). Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA 94: 13087-13092.[Abstract/Free Full Text]
  • Essers J., Hendriks RW, Swagemakers SM, Troelstra C., De Wit J., Bootsma D., Hoeijmakers JHJ, and Kanaar R. (1997). Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89: 195-204.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Esumi H., Ohgaki H., Kohzen E., Takayama S., and Sugimura T. (1989). Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 80: 1176-1178.[CrossRef][Web of Science]
  • Flammang TJ, Tungeln LSV, Kadlubar FF, and Fu PP (1997). Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay. Regul. Toxicol. Pharmacol. 26: 230-240.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Friedberg EC, Walker GC, and Siede W. (1995). DNA Repair and Mutagenesis. American Society for Microbiology Press, Washington, D.C.
  • Gunz D., Hess MT, and Naegeli H. (1996). Recognition of DNA adducts by human nucleotide excision repair: Evidence for a thermodynamic probing mechanism. J. Biol. Chem. 271: 25089-25098.[Abstract/Free Full Text]
  • He Z., Henricksen LA, Wold MS, and Ingles CJ (1995). RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature 374: 566-569.[CrossRef][Medline] [Order article via Infotrieve]
  • Hoeijmakers JHJ (1993). Nucleotide excision repair, I: From E. coli to yeast. Trends Genet. 9: 173-177.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoeijmakers JHJ (1993). Nucleotide excision repair, II: From yeast to mammals. Trends Genet. 9: 211-217.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoeijmakers JHJ and Bootsma D. (1990). Molecular genetics of eukaryotic DNA excision repair. Cancer Cells 2: 311-320.[Web of Science][Medline] [Order article via Infotrieve]
  • Ivanov EL and Haber JE (1997). DNA repair: RAD alert. Curr. Biol. 7: R492-R495.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jacks T., Remington L., Williams BO, Schmitt EM, Halachmi S., Bronson RT, and Weinberg RA (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.[Medline] [Order article via Infotrieve]
  • Jones CJ and Wood RD (1993). Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32: 12096-12104.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kanaar R. and Hoeijmakers JHJ (1997). Recombination and joining: Different means to the same ends. Genes Function 1: 165-174.[Medline] [Order article via Infotrieve]
  • Kerckaert GA, Brauninger R., LeBoeuf RA, and Isfort RJ (1996). Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the national toxicology program in rodent bioassays. Environ. Health Perspect. 104(suppl.): S1075-S1084.[CrossRef]
  • Kolodner RD (1995). Mismatch repair: Mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20: 397-401.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kraemer KH (1997). Sunlight and skin cancer: Another link revealed. Proc. Natl. Acad. Sci. USA 94: 11-14.[Free Full Text]
  • Kraemer KH, Lee MM, and Scotto J. (1984). DNA repair protects against cutaneous and internal neoplasia: Evidence from xeroderma pigmentosum. Carcinogenesis 5: 511-514.[Abstract/Free Full Text]
  • Leder A., Kuo A., Cardiff RD, Sinn E., and Leder P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87: 9178-9182.[Abstract/Free Full Text]
  • Lehmann AR (1995). Nucleotide excision repair and the link with transcription. Trends Biochem. Sci. 20: 402-405.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Littlefield NA, Cueto C., Davis AK, and Medlock K. (1975). Chronic dose-response studies in mice fed 2-AAF J. Toxicol. Environ. Health 1: 25-37.[Web of Science][Medline] [Order article via Infotrieve]
  • McGregor WG, Wei D., Chen RH, Maher VM, and McCormick JJ (1997). Relationship between adduct formation, rates of excision repair and the cytotoxic and mutagenic effects of structurally-related polycyclic aromatic carcinogens. Mutat. Res. 376: 143-152.[Web of Science][Medline] [Order article via Infotrieve]
  • McWhir J., Selfridge J., Harrison DJ, Squires S., and Melton DW (1993). Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat. Genet. 5: 217-224.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mellon I., Spivak G., and Hanawalt PC (1987). Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51: 241-249.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Miyamoto I., Miura N., Niwa H., Miyazaki J., and Tanaka K. (1992). Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. J. Biol. Chem. 267: 12182-12187.[Abstract/Free Full Text]
  • Modrich P. and Lahue R. (1996). Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65: 101-133.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Naegeli H. (1995). Mechanisms of DNA damage recognition in mammalian nucleotide excision repair. FASEB J. 9: 1043-1050.[Abstract]
  • Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., and Tanaka K. (1995) High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377: 165-168.[CrossRef][Medline] [Order article via Infotrieve]
  • Park CH, Bessho T., Matsunaga T., and Sancar A. (1995). Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease. J. Biol. Chem. 270: 22657-22660.[Abstract/Free Full Text]
  • Pegg AE (1990). Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50: 6119-6129.[Free Full Text]
  • Reardon JT, Bessho T., Chuan Kung H., Bolton PH, and Sancar A. (1997). In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA 94: 9463-9468.[Abstract/Free Full Text]
  • Reitmair AH, Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker HW, Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen WG, Fishel R., and Mak TW (1995). MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11: 64-70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., and Katsuki M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195-1200.[Web of Science][Medline] [Order article via Infotrieve]
  • Sands AT, Abuin A., Sanchez A., Conti CJ, and Bradley A. (1995). High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 377: 162-165.[CrossRef][Medline] [Order article via Infotrieve]
  • Satoh MS, Jones CJ, Wood RD, and Lindahl T. (1993). DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc. Natl. Acad. Sci. USA 90: 6335-6339.[Abstract/Free Full Text]
  • Schaeffer L., Roy R., Humbert S., Moncollin V., Vermeulen W., Hoeijmakers JHJ, Chambon P., and Egly JM (1993). DNA repair helicase: A component of BTF2 (TFIIH) basic transcription factor. Science 260: 58-63.[Abstract/Free Full Text]
  • Seeberg E., Eide L., and Bjoras M. (1995). The base excision repair pathway. Trends Biochem. Sci. 20: 391-397.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Taylor EM, Broughton BC, Botta E., Stefanini M., Sarasin A., Jaspers NG, Fawcett H., Harcourt SA, Arlett CF, and Lehmann AR (1997). Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. USA 94: 8658-8663.[Abstract/Free Full Text]
  • Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103: 942-950.[Web of Science][Medline] [Order article via Infotrieve]
  • Tennant RW, Spalding JW, and French JE (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and non-carcinogens. Mutat. Res. 365: 119-127.[Web of Science][Medline] [Order article via Infotrieve]
  • Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang SM, Shimizu S., Ishikawa T., Nakamura K., Nakao K., Katsuki M., and Sekuguchi M. (1996). Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis 17: 1215-1220.[Abstract/Free Full Text]
  • Van der Horst GT, Van Steeg H., Berg RJW, Van Gool AJ, De Wit J., Weeda G., Morreau H., Beems RB, Van Kreijl CF, De Gruijl FR, Bootsma D., and Hoeijmakers JHJ (1997 ). Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 89: 425-435.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Van Oostrom CThM, De Vries A., Verbeek SJ, Van Kreijl CF, and Van Steeg H. (1994). Cloning and characterization of the mouse XPAC gene. Nucleic Acids Res. 22: 11-14.[Abstract/Free Full Text]
  • Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers CJ, Nigg A., Van Steeg H., Bootsma D., and Hoeijmakers JHJ (1997). Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr. Biol. 7: 427-439.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Weeda G., van Ham RC, Vermeulen W., Bootsma D., van der Eb AJ, and Hoeijmakers JHJ (1990). A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 62: 777-791.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wood RD (1996). DNA repair in eukaryotes. Annu. Rev. Biochem. 65: 135-167.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yamamoto S., Urano K., Koizumi H., Wakana S., Hioki K., Mitsumori K., Kurokawa Y., Hayashi Y., and Nomura T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106(suppl.): S57-S69.

Toxicologic Pathology, Vol. 26, No. 6, 742-749 (1998)
DOI: 10.1177/019262339802600605
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
B. A.R. Lina, R. A. Woutersen, J. P. Bruijntjes, J. Van Benthem, J. A.H. Van Den Berg, J. Monbaliu, B. J.J.M. Thoolen, R. B. Beems, and C. F. Van Kreijl
Evaluation of the Xpa-Deficient Transgenic Mouse Model for Short-Term Carcinogenicity Testing: 9-Month Studies with Haloperidol, Reserpine, Phenacetin, and D-Mannitol
Toxicol Pathol, February 1, 2004; 32(2): 192 - 201.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
Y. Takahashi, Y. Nakatsuru, S. Zhang, Y. Shimizu, H. Kume, K. Tanaka, F. Ide, and T. Ishikawa
Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice
Carcinogenesis, April 1, 2002; 23(4): 627 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. Mortensen, M. Bertram, V. Aarup, and I. K. Sorensen
Assessment of Carcinogenicity of Di(2-ethylhexyl phthalate in a Short-Term Assay Using Xpa-/- and Xpa-/ - /p53+/-Mice
Toxicol Pathol, February 1, 2002; 30(2): 188 - 199.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
H. Miyauchi-Hashimoto, K. Kuwamoto, Y. Urade, K. Tanaka, and T. Horio
Carcinogen-Induced Inflammation and Immunosuppression Are Enhanced in Xeroderma Pigmentosum Group A Model Mice Associated with Hyperproduction of Prostaglandin E2
J. Immunol., May 1, 2001; 166(9): 5782 - 5791.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. E. Robinson and J. S. Macdonald
Background and Framework for ILSI's Collaborative Evaluation Program on Alternative Models for Carcinogenicity Assessment
Toxicol Pathol, January 1, 2001; 29(1_suppl): 13 - 19.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
C. F. Van Kreijl, P. A. Mcanulty, R. B. Beems, A. Vynckier, H. Van Steeg, R. Fransson-Steen, C. L. Alden, R. Forster, J.-W. Van der Laan, and J. Vandenberghe
Xpa and Xpa/p53+/- Knockout Mice: Overview of Available Data
Toxicol Pathol, January 1, 2001; 29(1_suppl): 117 - 127.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
J. Garssen, H. van Steeg, F. de Gruijl, J. de Boer, G. T. J. van der Horst, H. van Kranen, H. van Loveren, M. van Dijk, A. Fluitman, G. Weeda, et al.
Transcription-Coupled and Global Genome Repair Differentially Influence UV-B-Induced Acute Skin Effects and Systemic Immunosuppression
J. Immunol., June 15, 2000; 164(12): 6199 - 6205.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. Ide, N. Iida, Y. Nakatsuru, H. Oda, K. Tanaka, and T. Ishikawa
Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors
Carcinogenesis, June 1, 2000; 21(6): 1263 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann
Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment
Toxicol Pathol, May 1, 2000; 28(3): 482 - 499.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Van Steeg, H.
Right arrow Articles by Van Kreijl, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Steeg, H.
Right arrow Articles by Van Kreijl, C. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?